Angiogenesis and plastic surgery

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 61, Issue 12, 2008, Pages 1425-1437

  Akhavani, Mohammed Ali ^a,b,c   Sivakumar, Branavan ^a,b,c   Paleolog, Ewa M ^b   Kang, Norbert ^a,c  

^a Restoration of Appearance   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Flap survival; Fracture healing; Plastic surgery; Tendon healing; Ulcer healing

Indexed keywords

ADENOVIRUS VECTOR; ANGIOTENSIN I; BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; HYALURONIC ACID; IRINOTECAN; VASCULOTROPIN;

ANGIOGENESIS; BLOOD VESSEL; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR SYSTEM; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; COLON CANCER; ENDOTHELIUM CELL; FRACTURE HEALING; GENE THERAPY; GENE TRANSFER; GRAFT NECROSIS; HEALING; HUMAN; MELANOMA; NERVE REGENERATION; NONHUMAN; PATHOGENESIS; PATHOLOGY; PERIPHERAL VASCULAR DISEASE; PLASTIC SURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM CANCER; REVIEW; SKIN FLAP; SKIN FLAP SURVIVAL; SURVIVAL; TENDON; TISSUE EXPANSION; UPREGULATION;

ANGIOGENESIS INHIBITORS; GENE THERAPY; GROWTH SUBSTANCES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL FLAPS; WOUND HEALING;

EID: 55249109354     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2008.05.041     Document Type: Review

References (110)

1. Jain R.K. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
2. Breier G. Angiogenesis in embryonic development-a review. Placenta 21 Suppl A (2000) S11-S15
3. Breier G., Clauss M., and Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 204 (1995) 228-239
4. Matthews W., Jordan C.T., Gavin M., et al. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci U S A 88 (1991) 9026-9030
5. Yamaguchi T.P., Dumont D.J., Conlon R.A., et al. Flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118 (1993) 489-498
6. Carmeliet P., and Collen D. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 237 (1999) 133-158
7. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 (2003) 653-660
8. Patan S., Haenni B., and Burri P.H. Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM). Microvasc Res 53 (1996) 33-52
9. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
10. Ferrara N., Carver-Moore K., Chen H., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
11. Carmeliet P., Ferreira V., Breier G., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
12. Tischer E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266 (1991) 11947-11954
13. Neufeld G., Cohen T., Gengrinovitch S., et al. Vascular endothelial growth factor (VEGF) and its receptors. Faseb J 13 (1999) 9-22
14. Weige P, Chemistry and biology of hyaluronan ed. H Garg, Hales CA Chapter 25: The Hyaluronan Synthases, Elsevier 2004.
15. Gerecht S., Brudick J.A., and Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. PNAS 104 (2005) 11298-11303
16. Ingber D.E. Mechanical control of tissue morphogenesis during embryological development. Int J Dev Biol 50 (2006) 255-266
17. Cutting C., Bardach J., and Rosewall D. Skin flap delay procedures: proximal delay versus distal delay. Ann Plast Surg 4 (1980) 293-296
18. Barker J.H., et al. An animal model to study microcirculatory changes associated with vascular delay. Br J Plast Surg 52 (1999) 133-142
19. Pang C.Y., Forrest C.R., Neligan P.C., et al. Augmentation of blood flow in delayed random skin flaps in the pig: effect of length of delay period and angiogenesis. Plast Reconstr Surg 78 (1986) 68-74
20. Lineaweaver W.C., Lei M.P., Mustain W., et al. Vascular endothelium growth factor, surgical delay, and skin flap survival. Ann Surg 239 (2004) 866-873 [discussion: 873-875]
21. McFarlane R.M., Heagy F.C., Radin S., et al. A study of the delay phenomenon in experimental pedicle flaps. Plast Reconstr Surg 35 (1965) 245-262
22. Cherry G.W., Austad E., Pasyk K., et al. Increased survival and vascularity of random-pattern skin flaps elevated in controlled, expanded skin. Plast Reconstr Surg 72 (1983) 680-687
23. Lantieri L.A., Martin-Garcia N., Wechsler J., et al. Vascular endothelial growth factor expression in expanded tissue: a possible mechanism of angiogenesis in tissue expansion. Plast Reconstr Surg 101 (1998) 392-398
24. Wang F.S., Yang K.D., Wang C.J., et al. Shockwave stimulates oxygen radical-mediated osteogenesis of the mesenchymal cells from human umbilical cord blood. J Bone Miner Res 19 (2004) 973-982
25. Weber R.V., Navarro A., Wu J.K., et al. Pulsed magnetic fields applied to a transferred arterial loop support the rat groin composite flap. Plast Reconstr Surg 114 (2004) 1185-1189
26. Noma M., Tomoike H., Ando H., et al. Collateral development induced by repetitive brief coronary occlusion relates to the functional state of pre-existing collaterals. Jpn Circ J 58 (1994) 269-277
27. Meltzer T., and Myers B. The effect of hyperbaric oxygen on the bursting strength and rate of vascularization of skin wounds in the rat. Am Surg 52 (1986) 659-662
28. Bayati S., Russell R.C., and Roth A.C. Stimulation of angiogenesis to improve the viability of prefabricated flaps. Plast Reconstr Surg 101 (1998) 1290-1295
29. Fujihara Y., Koyama H., Ohba M., et al. Controlled delivery of bFGF to recipient bed enhances the vascularization and viability of an ischemic skin flap. Wound Repair Regen 16 (2008) 125-131
30. Kerrigan C.L., and Daniel R.K. Pharmacologic treatment of the failing skin flap. Plast Reconstr Surg 70 (1982) 541-549
31. Zhang F., Waller W., and Lineaweaver W.C. Growth factors and flap survival. Microsurgery 24 (2004) 162-167
32. Davis R.E., Wachholz J.H., Jassir D., et al. Comparison of topical anti-ischemic agents in the salvage of failing random-pattern skin flaps in rats. Arch Facial Plast Surg 1 (1999) 27-32
33. Myers M.B., and Cherry G. Mechanism of the delay phenomenon. Plast Reconstr Surg 44 (1969) 52-57
34. Schlaudraff K.U., Pepper M.S., Tkatchouk E.N., et al. Hypoxic preconditioning increases skin oxygenation and viability but does not alter VEGF expression or vascular density. High Alt Med Biol 9 (2008) 76-88
35. Padubidri A., and Browne Jr. E. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat. Ann Plast Surg 37 (1996) 604-611
36. Zhang F., Fischer K., Komorowska-Timek E., et al. Improvement of skin paddle survival by application of vascular endothelial growth factor in a rat TRAM flap model. Ann Plast Surg 46 (2001) 314-319
37. Seify H., Bulky U., and Jones G. Effect of vascular endothelial growth factor-induced angiogenesis on TRAM flap harvesting after abdominoplasty. Plast Reconstr Surg 111 (2003) 1212-1216
38. Lasso J.M., Del Rio M., Garcia M., et al. Improving flap survival by transplantation of a VEGF-secreting endothelised scaffold during distal pedicle flap creation. J Plast Reconstr Aesthet Surg 60 (2007) 279-286
39. Michlits W., Mittermayr R., Schafer R., et al. Fibrin-embedded administration of VEGF plasmid enhances skin flap survival. Wound Repair Regen 15 (2007) 360-367
40. Angel M.F., Ramasastry S.S., Swartz W.M., et al. The critical relationship between free radicals and degrees of ischemia: evidence for tissue intolerance of marginal perfusion. Plast Reconstr Surg 81 (1988) 233-239
41. Kerrigan C.L., and Daniel R.K. Critical ischemia time and the failing skin flap. Plast Reconstr Surg 69 (1982) 986-989
42. May Jr. J.W., Chait L.A., O'Brien B.M., et al. The no-reflow phenomenon in experimental free flaps. Plast Reconstr Surg 61 (1978) 256-267
43. May Jr. J.W., and Gallico III G.G. Upper extremity replantation. Curr Probl Surg 17 (1980) 633-717
44. Krum J.M., Mani N., and Rosenstein J.M. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 110 (2002) 589-604
45. Pettersson A., Nagy J.A., Brown L.F., et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80 (2000) 99-115
46. Kryger Z., Dogan T., Zhang F., et al. Effects of VEGF administration following ischemia on survival of the gracilis muscle flap in the rat. Ann Plast Surg 43 (1999) 172-178
47. Ashrafpour H., Huang N., Neligan P.C., et al. Vasodilator effect and mechanism of action of vascular endothelial growth factor in skin vasculature. Am J Physiol Heart Circ Physiol 286 (2004) H946-H954
48. Khan A., Ashrafpour H., Huang N., et al. Acute local subcutaneous VEGF165 injection for augmentation of skin flap viability: efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol 287 (2004) R1219-R1229
49. O'Toole G., MacKenzie D., Buckley M.F., et al. A review of therapeutic angiogenesis and consideration of its potential applications to plastic and reconstructive surgery. Br J Plast Surg 54 (2001) 1-7
50. Benjamin L.E., and Keshet E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci U S A 94 (1997) 8761-8766
51. Ilizarov G.A. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. Clin Orthop Relat Res (1989) 263-285
52. Saxena V., Hwang C.W., Huang S., et al. Vacuum-assisted closure: microdeformations of wounds and cell proliferation. Plast Reconstr Surg 114 (2004) 1086-1096 [discussion: 1097-1098]
53. Banwell P.E., and Teot L. Topical negative pressure (TNP): the evolution of a novel wound therapy. J Wound Care 12 (2003) 22-28
54. Quinn T.P., Schlueter M., Soifer S.J., et al. Cyclic mechanical stretch induces VEGF and FGF-2 expression in pulmonary vascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 282 (2002) L897-L903
55. Urschel J.D., Scott P.G., and Williams H.T. The effect of mechanical stress on soft and hard tissue repair; a review. Br J Plast Surg 41 (1988) 182-186
56. Morykwas M.J., Simpson J., Punger K., et al. Vacuum-assisted closure: state of basic research and physiologic foundation. Plast Reconstr Surg 117 Suppl. 7 (2006) 121S-126S
57. Labler L., Mica L., Harter L., et al. Influence of V.A.C.-therapy on cytokines and growth factors in traumatic wounds. Zentralbl Chir 131 Suppl. 1 (2006) S62-S67
58. Clover A.J., and McCarthy M.J. Developing strategies for therapeutic angiogenesis: vascular endothelial growth factor alone may not be the answer. Br J Plast Surg 56 (2003) 314
59. Risau W. Mechanisms of angiogenesis. Nature 386 (1997) 671-674
60. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
61. Asahara T., Chen D., Takahashi T., et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83 (1998) 233-240
62. Jung H., Gurunluoglu R., Scharpf J., et al. Adenovirus-mediated angiopoietin-1 gene therapy enhances skin flap survival. Microsurgery 23 (2003) 374-380
63. Chae J.K., Kim I., Lim S.T., et al. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler Thromb Vasc Biol 20 (2000) 2573-2578
64. Stein V., Laprell H., Tinnemeyer S., et al. Quantitative assessment of intravascular volume of the human Achilles tendon. Acta Orthop Scand 71 (2000) 60-63
65. Ahmed I.M., Lagopoulos M., McConnell P., et al. Blood supply of the Achilles tendon. J Orthop Res 16 (1998) 591-596
66. Amiel D., Kleiner J.B., Roux R.D., et al. The phenomenon of "ligamentization": anterior cruciate ligament reconstruction with autogenous patellar tendon. J Orthop Res 4 (1986) 162-172
67. Petersen W., Pufe T., Unterhauser F., et al. The splice variants 120 and 164 of the angiogenic peptide vascular endothelial cell growth factor (VEGF) are expressed during Achilles tendon healing. Arch Orthop Trauma Surg 123 (2003) 475-480
68. Kannus P., and Jozsa L. Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients. J Bone Joint Surg Am 73 (1991) 1507-1525
69. Street J., Bao M., deGuzman L., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 99 (2002) 9656-9661
70. Pufe T., Wildemann B., Petersen W., et al. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 309 (2002) 387-392
71. Hiltunen M.O., Ruuskanen M., Huuskonen J., et al. Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. Faseb J 17 (2003) 1147-1149
72. Hobson M.I. Increased vascularisation enhances axonal regeneration within an acellular nerve conduit. Ann R Coll Surg Engl 84 (2002) 47-53
73. Pola R., Aprahamian T.R., Bosch-Marce M., et al. Age-dependent VEGF expression and intraneural neovascularization during regeneration of peripheral nerves. Neurobiol Aging 25 (2004) 1361-1368
74. Drinkwater S.L., Burnand K.G., Ding R., et al. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers. J Vasc Surg 38 (2003) 1106-1112
75. Brem H., Tomic-Canic M., Tarnovskaya A., et al. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers. Surg Technol Int 11 (2003) 161-167
76. Drinkwater S.L., Smith A., Sawyer B.M., et al. Effect of venous ulcer exudates on angiogenesis in vitro. Br J Surg 89 (2002) 709-713
77. Romano Di Peppe S., Mangoni A., Zambruno G., et al. Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther 9 (2002) 1271-1277
78. Kim H.J., Jang S.Y., Park J.I., et al. Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease. Exp Mol Med 36 (2004) 336-344
79. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg 175 (1972) 409-416
80. Hollingsworth H.C., Kohn E.C., Steinberg S.M., et al. Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147 (1995) 33-41
81. Konerding M.A., Malkusch W., Klapthor B., et al. Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts. Br J Cancer 80 (1999) 724-732
82. Wouters B.G., Weppler S.A., Koritzinsky M., et al. Hypoxia as a target for combined modality treatments. Eur J Cancer 38 (2002) 240-257
83. Fava R.A., Olsen N.J., Spencer-Green G., et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180 (1994) 341-346
84. Paleolog E.M., and Fava R.A. Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies. Springer Semin Immunopathol 20 (1998) 73-94
85. Cramer T., Yamanishi Y., Clausen B.E., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 (2003) 645-657
86. Bates D.O., Cui T.G., Doughty J.M., et al. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62 (2002) 4123-4131
87. Woolard J., Wang W.Y., Bevan H.S., et al. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64 (2004) 7822-7835
88. Perrin R.M., Konopatskaya O., Qiu Y., et al. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 48 (2005) 2422-2427
89. Konopatskaya O., Churchill A.J., Harper S.J., et al. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 12 (2006) 626-632
90. Pritchard-Jones R.O., Dunn D.B., Qiu Y., et al. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. Br J Cancer 97 (2007) 223-230
91. Presta L.G., Chen H., O'Connor S.J., et al. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57 (1997) 4593-4599
92. Kabbinavar F., Hurwitz H.L., Fehrenbacher L., et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 21 (2003) 60-65
93. Paleolog E.M., Young S., Stark A.C., et al. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis. Rheum. 41 (1998) 1258-1265
94. Sivakumar B., Akhavani M.A., Winlove C.P., et al. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg [Am] 33 (2008) 49-58
95. Lu J., Kasama T., Kobayashi K., et al. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol 164 (2000) 5922-5927
96. Lubiatowski P., Gurunluoglu R., Goldman C.K., et al. Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps. Plast Reconstr Surg 110 (2002) 149-159
97. Yancopoulos G.D., Davis S., Gale N.W., et al. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
98. Kryger Z., Zhang F., Dogan T., et al. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 53 (2000) 234-239
99. Yla-Herttuala S., and Martin J.F. Cardiovascular gene therapy. Lancet 355 (2000) 213-222
100. Tsurumi Y., Takeshita S., Chen D., et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94 (1996) 3281-3290
101. Mack C.A., Magovern C.J., Budenbender K.T., et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg 27 (1998) 699-709
102. Taub P.J., Marmur J.D., Zhang W.X., et al. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps. Plast Reconstr Surg 102 (1998) 2033-2039
103. Shyu K.G., Manor O., Magner M., et al. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98 (1998) 2081-2087
104. Benest A.V., Salmon A.H., Wang W., et al. VEGF and angiopoietin-1 stimulate different angiogenic phenotypes that combine to enhance functional neovascularization in adult tissue. Microcirculation 13 (2006) 423-437
105. Patel S.R., Lee L.Y., Mack C.A., et al. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gene Ther 10 (1999) 1331-1348
106. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
107. Tepper O.M., Galiano R.D., Kalka C., et al. Endothelial progenitor cells: the promise of vascular stem cells for plastic surgery. Plast Reconstr Surg 111 (2003) 846-854
108. Yi C., Xia W., Zheng Y., et al. Transplantation of endothelial progenitor cells transferred by vascular endothelial growth factor gene for vascular regeneration of ischemic flaps. J Surg Res 135 (2006) 100-106
109. Zheng Y., Yi C., Xia W., et al. Mesenchymal stem cells transduced by vascular endothelial growth factor gene for ischemic random skin flaps. Plast Reconstr Surg 121 (2008) 59-69
110. Lu F., Mizuno H., Uysal C.A., et al. Improved viability of random pattern skin flaps through the use of adipose-derived stem cells. Plast Reconstr Surg 121 (2008) 50-58